Market Monitor - 12 February 2021

Market Monitor – 12 February 2021

Global stock markets have extended their February gains this week, although most indices have struggled to maintain the stellar performance seen at the start of the month. For the time being at least, there is a clear tension between optimism that the roll-out of Covid-19 vaccines around the world will soon enable major economies in Europe and North America to return to normal, and concern that the emergence of new, vaccine-resistant variants of the coronavirus could prolong the pandemic. One of the main worries is that the cheaper, more versatile vaccine developed by AstraZeneca with Oxford University has been found in some studies to be less effective against the highly infectious variant that is currently dominant in South Africa. But with a number of countries imposing strict new quarantine requirements on international arrivals, there are hopes that the spread of this variant can be contained. Investors were buoyed at the start of the week by economic data from China showing a strong recovery in domestic car sales, an important indicator of consumer confidence. Markets also expect the extra stimulus spending in the United States to drive share prices higher around the world. Meanwhile, investor interest in cryptocurrencies surged again this week after Tesla boss Elon Musk revealed his company had made a significant Bitcoin purchase – and would in future sell cars priced in the currency.

US markets

On Wall Street, the Dow Jones Industrial Average ended trading on Thursday 0.9% up for the week so far, with the S&P 500 similarly 0.8% ahead. Share prices in the US are being kept afloat by government stimulus hopes, while Federal Reserve chairman Jerome Powell also helped to calm nerves by stating the Fed would not rush to raise interest rates while the American economy was recovering.

The UK & Europe

In the UK, the FTSE 100 ended Thursday 0.6% ahead for the week as Britain’s vaccination roll-out continued apace. Almost a fifth of the population – including the vast majority of the over-75s – have now received either an AstraZeneca or Pfizer shot. The impact of the inoculations on infection rates and hospital admissions among older people should, in theory, start feeding through into official statistics over the next few weeks. Britain’s international trade, meanwhile, continues to suffer as a result of problems caused by the new border arrangements with the European Union. Reports suggest that UK exports to the bloc were down by more than 60% in January, while forecasts published by Brussels suggested that Britain would take a far bigger medium-term hit to GDP than the EU as a result of Brexit. In Frankfurt, the DAX index ended Thursday’s session down 0.1% for the week following last week’s surge, while France’s CAC 40 gained 0.2%. The vaccine roll-out across the eurozone remains stuck in first gear, but the European Commission has nonetheless predicted that Europe’s major economies will return to pre-pandemic levels sooner than previously expected.
Change (%)
FTSE 100
FTSE All-share
S&P 500
Dow Jones

Note: all market data contained within the article is sourced from Bloomberg unless stated otherwise, data as at 04/02/2021.

12 February 2021
Mark King
Head of Investment Content
Share article
Share on twitter
Share on linkedin
Share on email
Key topics
Related topics
Share article
Share on twitter
Share on linkedin
Share on email
Key topics
Related topics


Market Monitor – 12 February 2021

Important information

Past performance is not a guide to future performance. Your capital is at risk. The value of investments and any income is not guaranteed and can go down as well as up and may be affected by exchange rate fluctuations. This means that an investor may not get back the amount invested. This document is not investment, legal, tax, or accounting advice. Investors should consult with their own professional advisors for advice on any investment, legal, tax, or accounting issues relating to an investment with Columbia Threadneedle Investments. The analysis included in this document has been produced by Columbia Threadneedle Investments for its own investment management activities, may have been acted upon prior to publication and is made available here incidentally. Any opinions expressed are made as at the date of publication but are subject to change without notice and should not be seen as investment advice. This document includes forward looking statements, including projections of future economic and financial conditions. None of Columbia Threadneedle Investments, its directors, officers or employees make any representation, warranty, guaranty, or other assurance that any of these forward-looking statements will prove to be accurate. Information obtained from external sources is believed to be reliable, but its accuracy or completeness cannot be guaranteed. Issued by Threadneedle Asset Management Limited. Registered in England and Wales, Registered No. 573204, Cannon Place, 78 Cannon Street, London EC4N 6AG, United Kingdom. Authorised and regulated in the UK by the Financial Conduct Authority. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies.

Related Insights

6 May 2022

Mark King

Head of Investment Content

Market Monitor - 6 May 2022

Rising interest rates and the threat of a new global recession have caused renewed turbulence on stock markets around the world this week, with high levels of uncertainty and anxiety among investors leading to major swings.
Read time - 2 min
8 April 2022

Mark King

Head of Investment Content

Market Monitor - 8 April 2022

The threat of tighter monetary policy and the expectation of further negative economic impacts from the war in Ukraine have driven global share prices lower this week.
Read time - 2 min
25 March 2022

Mark King

Head of Investment Content

Market Monitor - 25 March 2022

Global stock markets have enjoyed a more or less positive week as investors have once again been happy to focus on whatever good news they can find.
Read time - 2 min

You may also like

Investment approach

Teamwork defines us and is fundamental to our investment approach, which is structured to facilitate the generation, assessment and implementation of good, strong investment ideas for our portfolios.

Find your fund

Columbia Threadneedle Investments has a comprehensive range of investment funds catering for a broad range of objectives.

Types of investment

We offer a broad range of actively managed investment strategies and solutions covering global, regional and domestic markets and asset classes.